BARBARA BAYKO: Open Payments
NPI 1174660476 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$699 in 35 payments from 14 companies in 2025. Trend: 2023 $1,282 · 2024 $1,678 · 2025 $699
Food & beverage: $699
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $89 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $81 |
| Corcept Therapeutics | 3 | $79 |
| Novo Nordisk Inc | 4 | $78 |
| ABBVIE INC. | 4 | $74 |
| AstraZeneca Pharmaceuticals LP | 4 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $61 |
| Astellas Pharma US Inc | 2 | $44 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Insulet Corporation | 1 | $23 |
Products named: FREESTYLE LIBRE 3, Kerendia, Korlym, AIRSUPRA, JARDIANCE, Veozah, Ozempic, GARDASIL 9.
Industry payments across FL — which companies pay providers there.
